Latest Articles
Comparative effectiveness of hormonal therapies for preventing recurrence in endometriosis: a real-world retrospective cohort study with risk factor analysis.
Endometriosis is a common chronic disease in women of reproductive age, and long-term postoperative medical management is a key strategy for preventing recurrence. Currently used clinical medications include dienogest (DNG), …
Published: June 30, 2026, midnight
Surgical Outcomes of Open, Laparoscopic, and Robotic-Assisted Approaches for Stage I Endometrial Cancer: Insights From a Real-World Study by the Indian Gynecologic-Onco Study Group - Cureus
Surgical Outcomes of Open, Laparoscopic, and Robotic-Assisted Approaches for Stage I Endometrial Cancer: Insights From a Real-World Study by the Indian Gynecologic-Onco Study Group Cureus
Published: Aug. 23, 2025, 6:05 a.m.
Mismatch Repair Status Linked to Endometrial Cancer Outcomes, Real-World Study Reveals - Medscape
Mismatch Repair Status Linked to Endometrial Cancer Outcomes, Real-World Study Reveals Medscape
Published: Aug. 11, 2025, noon
Real-World Study on Adverse Drug Reactions of Pembrolizumab in Endometrial Cancer Treatment: Insights from the FAERS Database - Frontiers
Real-World Study on Adverse Drug Reactions of Pembrolizumab in Endometrial Cancer Treatment: Insights from the FAERS Database Frontiers
Published: Aug. 6, 2025, 2:27 p.m.
Postmarketing adverse events of tamoxifen in male and female patients with breast cancer.
Tamoxifen (TAM), a selective estrogen receptor (ER) modulator, has received approval for use in patients with breast cancer (BC) exhibiting positive ER expression. Given the widespread clinical use of TAM, …
Published: Sept. 21, 2024, midnight
Link copied to clipboard!